London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck's VC arm, M Ventures (Mimi Billing/Sifted)
Mimi Billing / Sifted: London-based LabGenius, which makes use of ML to seek out and design antibody remedies to regard ...
